A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
Clinical trial NCT05402371 · UNKNOWN
Trial details
- NCT number
- NCT05402371
- Sponsor
- Hepion Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-15
- Primary completion
- 2025-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.